Schulmeister Lisa, Quiett Kimberly, Mayer Kelly
Oncol Nurs Forum. 2005 Jan 19;32(1):57-67. doi: 10.1188/05.ONF.57-67.
PURPOSE/OBJECTIVES: To further expand the limited body of knowledge of the perceptions of quality of life (QOL), quality of care, and patient satisfaction among patients who receive high-dose chemotherapy with an autologous stem cell transplant (ASCT) on an outpatient basis.
Descriptive longitudinal.
Nine clinical sites associated with a national oncology practice management network in locations across the United States.
36 patients scheduled to receive high-dose chemotherapy with ASCT selected by nonprobability consecutive sampling.
Subjects completed the Functional Assessment of Cancer Therapy Bone Marrow Transplant (FACT-BMT) before high-dose chemotherapy, four to six weeks postchemotherapy, and six months postchemotherapy. An independent nurse researcher conducted telephone interviews about the treatment experience, perceptions of quality of care, and satisfaction with care. FACT-BMT data were analyzed using descriptive statistics and multivariate analysis of variance, and qualitative data about perceptions of care were analyzed using Giorgis methodologic reduction. Bivariate associations were made between overall degree of satisfaction with care and QOL as measured by the FACT-BMT.
Clinical outcome, QOL, patient satisfaction, and patient perceptions of care quality.
Mean FACT-BMT scores were lower one month post-treatment than at baseline and highest six months post-treatment. Subjects with progressive disease reported lower QOL at one and six months post-treatment, noted more complaints, and ranked their satisfaction with care lower than subjects with no evidence of disease. Subjects offered ASCT program improvement recommendations in the areas of communication, information, nursing care, ancillary needs assistance, ancillary agencies, and survivor support.
In this study, the QOL of patients undergoing outpatient high-dose chemotherapy with ASCT decreased post-treatment but increased to levels higher than those found at pretreatment by six months. A good clinical outcome following high-dose chemotherapy and ASCT was associated with higher QOL and greater satisfaction with care.
Knowledge of the outpatient ASCT experience and its effect on QOL can be used to further refine the content and timing of educational and supportive interventions for patients undergoing ASCT. Information about patients satisfaction with treatment and perceptions of quality of care provides insight about their expectations and perceived needs and can be used to redesign outpatient ASCT programs.
目的/目标:进一步扩充关于接受门诊自体干细胞移植(ASCT)高剂量化疗患者的生活质量(QOL)认知、护理质量及患者满意度方面有限的知识体系。
描述性纵向研究。
与美国各地一个全国肿瘤实践管理网络相关的九个临床地点。
通过非概率连续抽样选取36例计划接受ASCT高剂量化疗的患者。
受试者在高剂量化疗前、化疗后四至六周以及化疗后六个月完成癌症治疗功能评估骨髓移植量表(FACT - BMT)。一名独立的护士研究员就治疗经历、护理质量认知及护理满意度进行电话访谈。FACT - BMT数据采用描述性统计和多变量方差分析进行分析,关于护理认知的定性数据采用 Giorgis 方法简化进行分析。通过FACT - BMT测量护理总体满意度与QOL之间进行双变量关联分析。
临床结局/QOL/患者满意度以及患者对护理质量的认知。
治疗后一个月的FACT - BMT平均得分低于基线水平,治疗后六个月最高。疾病进展的受试者在治疗后一个月和六个月报告的QOL较低,抱怨更多,对护理的满意度排名低于无疾病证据的受试者。受试者在沟通、信息、护理、辅助需求协助、辅助机构及幸存者支持等方面提出了ASCT项目改进建议。
在本研究中,接受门诊ASCT高剂量化疗的患者治疗后的QOL下降,但六个月后升至高于治疗前的水平。高剂量化疗和ASCT后的良好临床结局与更高的QOL及更高的护理满意度相关。
了解门诊ASCT经历及其对QOL的影响可用于进一步完善针对接受ASCT患者的教育和支持性干预的内容和时机。关于患者对治疗的满意度及护理质量认知的信息可洞察他们的期望和感知需求,并可用于重新设计门诊ASCT项目。